Filing Details
- Accession Number:
- 0001110803-13-000307
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-09-09 20:05:49
- Reporting Period:
- 2013-09-05
- Filing Date:
- 2013-09-09
- Accepted Time:
- 2013-09-09 20:05:49
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1110803 | Illumina Inc | ILMN | Laboratory Analytical Instruments (3826) | 330804655 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1263805 | O Christian Henry | 5200 Illumina Way San Diego CA 92122 | Sr Vp, General Manager Genomic | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-09-05 | 6,000 | $28.45 | 36,236 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-09-05 | 2,400 | $77.64 | 33,836 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-09-05 | 3,600 | $78.24 | 30,236 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2013-09-05 | 3,000 | $32.49 | 33,236 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-09-05 | 3,000 | $78.51 | 30,236 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2013-09-05 | 6,000 | $0.00 | 6,000 | $28.45 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2013-09-05 | 3,000 | $0.00 | 3,000 | $32.49 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 51,000 | 2009-02-28 | 2019-01-28 | No | 4 | M | Direct |
| 0 | 2008-02-29 | 2018-01-29 | No | 4 | M | Direct |
Footnotes
- The sale was made pursuant to a 10b5-1 plan.
- Weighted average sales price representing 2,400 shares sold ranging from $77.04 to $78.02 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sales price representing 3,600 shares sold ranging from $78.04 to $78.34 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sales price representing 3,000 shares sold ranging from $78.34 to $78.72 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Balance includes 282 shares acquired on Aug. 1, 2013 through Employee Stock Purchase Plan.
Billionaire Hedge Funds
